Lymphomation.org > Treatments

Last update: 05/05/2009

Take a moment to help Support our Mission

Antibodies (monoclonal) such as Rituxan

Biologics  such as Interferon, Neupogen, Leukine 

Bone marrow (stem cell) transplants  

Allogeneic: Mini / Autologous / Cord blood 
Comparing Auto and Allo SCT   
HLA-typing | Background
Harvesting / Mobilizing stem cells 
Graft vs Host Disease | Patient stories  Resources   

Chemotherapy

Alphabetical index of individual agents
Agents (individual) grouped by mechanism  
CHOP chemotherapy  
Common chemo protocols (APO...VBM)  
Liposomal (encapsulated) types 
Low dose (metronomic) chemotherapy PEP-C Outcome abstracts - Frontline Treatment support for chemotherapy

Clinical Trials

Lymphoma subtype 
Treatment type  
State or Country 
Other  - age ... stage, phase, refractory  
Clinical Trials of Interest for Lymphoma

Complementary and Alternative Medicine

Elderly patients - treatment protocols and resources

Emerging Therapies and Targets index of investigative therapies &  treatment targets, containing brief explanations.
 
     Also see Pipeline with links to clinical trials

Evaluating medical claims recognizing bias; limits of abstracts, what makes information credible.

Immune-based therapies

Lower toxic treatments  

MDS (Myelodysplastic Syndrome)

Nanotechnology

Photopheresis 

Pipeline new agents with links to clinical trials

Pregnancy During Lymphoma Treatment

Progress Review Group  (PRG) research objectives

Radio-immunotherapy

Bexxar  ... centers
Zevalin  ... centers 
Comparing Bexxar/Zevalin 
RIT for bulky disease?

Refractory lymphomas  
abstracts on protocols for 
treating lymphomas resistant to standard therapies

Protocols | Clinical Trials

Remissions & Response background & terms

Also Spontaneous regressions

Rituxan - Basics ... Side effects ...
 
               Check list what to expect, bring, do.

     Abstracts on outcomes | Maintenance? 

Side effects common to treatments

Splenectomy

Stem cell Transplant

Surgery for Lymphoma? (a common question)

Therapy-related risks balancing risks and benefits

Treatment Decisions - Factors that Influence

Goals | Types | Outcomes | Interventions  

Considerations at relapse

Treatment decisions - factors that can influence treatment goal, type, and timing

Outcome abstracts

NCCN Clinical Practice Guidelines in Oncology™ NHL, 2008 nccn.org  PDF 
  
Treatment Support 

Treatment Timing?

Time to Progression comparing protocols for first line treatment of indolent NHL | Frontline

Treatment settings frontline, relapse, survival

Watchful Waiting

Transformation background and treatment

Vaccines  investigational patient-specific therapeutic vaccines

Categorized abstracts | Outcome Data

What's a Drug?